Janux Therapeutics Inc (NAS:JANX) Stock News, Headlines & Updates
Janux Therapeutics Inc Stock News from GuruFocus
- 1
May 15, 2025
Janux Therapeutics Inc (JANX) Appoints New Chief Corporate and Business Development Officer | JANX stock news
GuruFocus News • 8:19am
Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer
Business Wire • 8:00am
Janux Therapeutics (JANX) Welcomes New Chief Corporate and Business Development Officer | JANX Stock News
GuruFocus News • 7:30am
May 09, 2025
Janux Therapeutics (JANX) Reports Q1 EPS Loss, Maintains Strong Cash Position
GuruFocus News • 12:58pm
Scotiabank Adjusts Janux Therapeutics (JANX) Price Target Amid Trial Concerns | JANX Stock News
GuruFocus News • 9:47am
Decoding Janux Therapeutics Inc (JANX): A Strategic SWOT Insight
GuruFocus News • 11:32pm
May 08, 2025
Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
Business Wire • 4:00pm
Janux Therapeutics Inc Reports Q1 2025 EPS of -$0.38, Beating Estimates; No Revenue Reported, Missing $0.56 Million Estimate
GuruFocus News • 3:40pm
Janux Therapeutics (JANX) Advances Clinical Trials for JANX007 | JANX Stock News
GuruFocus News • 3:17pm
May 05, 2025
Janux Therapeutics (JANX) Begins Phase 1b Expansion for Prostate Cancer Trial | JANX Stock News
GuruFocus News • 8:46am
Janux Therapeutics Inc (JANX) Initiates Phase 1b Expansion Studies for Prostate Cancer Treatment | JANX stock news
GuruFocus News • 8:06am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news